• 1. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002
• 2. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 3. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 4. Distributed research: a new paradigm for undergraduate research and global problem solving?
  Bruce Parkinson Energy Environ. Sci., 2010,3, 509-511
• 5. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Methoxyanilines
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Aniline and substituted anilines Methoxyanilines

Professional Introduction to Compound with CAS No. 893328-15-9 and Product Name: 2-(4-chloro-2-methylphenoxy)-N-{[(4-methoxyphenyl)carbamothioyl]amino}acetamide

The compound with the CAS number 893328-15-9 and the product name 2-(4-chloro-2-methylphenoxy)-N-{[(4-methoxyphenyl)carbamothioyl]amino}acetamide represents a significant advancement in the field of pharmaceutical chemistry. This compound, characterized by its unique structural framework, has garnered considerable attention due to its potential applications in medicinal chemistry and drug development. The molecular architecture of this compound incorporates several key functional groups that contribute to its pharmacological properties, making it a subject of intense research interest.

At the core of this compound's structure lies the 4-chloro-2-methylphenoxy moiety, which is known for its ability to enhance binding affinity and selectivity in biological targets. This group, when combined with the (4-methoxyphenyl)carbamothioylamino segment, creates a synergistic effect that modulates various cellular pathways. The presence of the acetamide group further contributes to the compound's solubility and bioavailability, making it a promising candidate for further exploration in therapeutic applications.

Recent studies have highlighted the importance of phenoxyacetamide derivatives in the development of novel pharmaceutical agents. These derivatives have shown promise in targeting a wide range of diseases, including cancer, inflammation, and neurological disorders. The specific configuration of the 2-(4-chloro-2-methylphenoxy)-N-{[(4-methoxyphenyl)carbamothioyl]amino}acetamide molecule aligns well with these trends, offering a unique scaffold for drug discovery.

In particular, the 4-methoxyphenyl group within the compound's structure has been identified as a critical component for its pharmacological activity. Research indicates that this moiety can interact with specific enzymes and receptors, leading to modulatory effects on cellular signaling pathways. Such interactions are crucial for developing drugs that can effectively address complex diseases without unintended side effects.

The carbamothioyl moiety in the compound's name is another key feature that contributes to its therapeutic potential. This group has been extensively studied for its ability to enhance binding interactions with biological targets, thereby increasing the efficacy of pharmaceutical agents. The combination of this group with the acetamide moiety results in a molecule that is both structurally stable and biologically active.

Current research in medicinal chemistry is increasingly focused on developing small molecules that can modulate protein-protein interactions (PPIs). The compound under discussion exhibits properties that make it a suitable candidate for this area of research. Its ability to interact with specific PPIs could lead to the development of novel therapeutic strategies for diseases that are currently difficult to treat.

Moreover, the structural features of this compound make it amenable to further chemical modifications. Researchers can explore various synthetic pathways to optimize its pharmacological properties, potentially leading to more effective and safer pharmaceutical agents. The versatility of this molecular scaffold allows for a wide range of modifications, making it a valuable tool in drug discovery.

The synthesis of 2-(4-chloro-2-methylphenoxy)-N-{[(4-methoxyphenyl)carbamothioyl]amino}acetamide involves a series of well-established chemical reactions that highlight its feasibility as a pharmaceutical candidate. The use of readily available starting materials and standard synthetic protocols ensures that large-scale production is feasible. This aspect is crucial for translating laboratory discoveries into clinical applications.

In conclusion, the compound with CAS number 893328-15-9 and product name 2-(4-chloro-2-methylphenoxy)-N-{[(4-methoxyphenyl)carbamothioyl]amino}acetamide represents a significant advancement in pharmaceutical chemistry. Its unique structural features and potential applications in drug development make it a subject of considerable interest among researchers. As further studies continue to uncover its pharmacological properties, this compound holds promise for contributing to the development of novel therapeutic agents that can address various diseases.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)